Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

New study finds that Black children and those identifying with more than one race have higher disease activity and are less likely to achieve low lupus disease activity state compared to White ...

Use your power! Find your walk and register your team today. Fundraise We provide you with all the tools you need to fundraise for lupus research, support and education services all while earning ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...